Ankyra Therapeutics Appoints Howard L. Kaufman, MD as President and Chief Executive Officer

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

New York ,United States ,Rutgers University ,New Jersey ,Ankyra ,Ankara ,Turkey ,Massachusetts ,Boston ,Rush University ,Illinois ,Chicago ,Tillman Gerngross ,Noah Oshry ,Howard Kaufman ,Amgen Talimogene ,Howardl Kaufman ,Society For Immunotherapy Of Cancer ,Professor At Rutgers University ,Herbert Irving Cancer Center At Columbia University ,Replimune Inc ,Cancer Center ,Harvard Medical School ,Head Of Research Development At Immuneering Corp ,Serono ,Chief Executive Officer ,Chief Medical Officer ,Co Founder Tillman Gerngross ,Associate Director ,Herbert Irving Cancer Center ,Columbia University ,New York City ,Associate Dean ,Cancer Center Director ,Massachusetts General Hospital ,Massachusetts Eye ,Ear Infirmary ,Harvard Medical ,For Investor Inquiries ,Ankyra Therapeutics ,Business Wire ,Business ,Health ,Cancer ,Board Of Directors ,